Drug nonadherence prevalent in type 2 diabetes patients

07/25/2013 | InternalMedicineNews.com (free registration)

Research presented at the American Diabetes Association's 73rd Scientific Sessions showed the one-year drug discontinuation rate among type 2 diabetes patients was 89% in those taking a glucagon-like peptide-1 agonist, 82% in those who took a dipeptidyl-peptidase-4 inhibitor and 84% in those treated with other diabetes drugs. The findings highlight the need for better persistence with GLP-1 agonist therapy, the lead researcher said.

View Full Article in:

InternalMedicineNews.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC